Federal Officials Call Cannabis a “Deadly” Drug, Sparking Backlash

The latest cannabis policy updates show a divided landscape. While U.S. Customs and Border Protection is doubling down on "deadly drug" rhetoric, several states are making moves that actually help the community. California just implemented a much-needed tax break for the legal market, which should help keep prices down for consumers through 2028. Meanwhile, Massachusetts is leading the way on plant medicine, with a legislative committee greenlighting a psychedelic therapy pilot program. In the Midwest, Nebraska’s medical program is facing delays due to regulator resignations, and Michigan businesses are fighting back against proposed tax hikes.

These updates are a mixed bag for everyday tokers. The federal government’s stance is a reminder that we’re still fighting old stigmas, but the state-level tax wins in California are a huge relief for those of us supporting the legal industry. For the community, these legislative shifts matter because they directly impact how much you pay at the register and how safe the legal market remains against over-taxation and federal overreach.